Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial. (2020)
Attributed to:
MRC Centre for Medical Mycology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0229380
PubMed Identifier: 32130261
Publication URI: http://europepmc.org/abstract/MED/32130261
Type: Journal Article/Review
Volume: 15
Parent Publication: PloS one
Issue: 3
ISSN: 1932-6203